This inventor holds 5 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Abbott Diabetes Care Inc., University of Cambridge. Active years: 2011-2022.
Company Filing History:
5 out of 1,442 
4 out of 439 
Years Active: 2011-2022
Title: Malgorzata E Wilinska: Innovator in Diabetes Management
Introduction
Malgorzata E Wilinska is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of diabetes management through her innovative patents. With a total of 5 patents, her work focuses on improving insulin delivery systems and reducing hypoglycemic alarm occurrences.
Latest Patents
One of her latest patents is titled "Integrated closed-loop medication delivery with error model and safety check." This closed-loop system for insulin infusion utilizes a model predictive control algorithm (MPC). The MPC is paired with a glucose measurement error model derived from actual glucose sensor error data. This data includes both sensor artifacts and persistent error components obtained experimentally from living subjects. The MPC algorithm advises on insulin infusion every fifteen minutes, significantly reducing the incidence of severe and significant hypoglycemia during simulated overnight closed-loop control.
Another notable patent is "Methods for reducing false hypoglycemia alarm occurrence." This system employs model-based state estimation and variable-delayed threshold values to balance the risk of not presenting an alarm for actual hypoglycemic states against the presentation of alarms caused by artifacts in signals from continuous glucose monitors.
Career Highlights
Malgorzata has worked with reputable organizations such as Abbott Diabetes Care Inc. and the University of Cambridge. Her experience in these institutions has allowed her to develop and refine her innovative approaches to diabetes management.
Collaborations
Malgorzata has collaborated with notable individuals in her field, including Erwin Satrya Budiman and Gary Alan Hayter. These collaborations have further enhanced her research and development efforts.
Conclusion
Malgorzata E Wilinska is a trailblazer in the field of diabetes management, with her innovative patents paving the way for safer and more effective insulin delivery systems. Her contributions are vital in improving the quality of life for individuals living with diabetes.